Main Content

Press Release

Elekta Launches New Version of Monaco Treatment Planning System Designed for Elekta VMAT Delivery

Atlanta, GA

2010-06-10

Advanced arc therapy delivery technique further optimized with gold standard planning, helping doctors to provide best possible treatment for patients


Elekta recently announced the latest production release of its Monaco® treatment planning system, version 2.03, which is designed to enhance planning for Elekta VMAT. Monaco provides key features that aid clinicians in planning around structures effectively for Elekta VMAT delivery and accurately predict the total dose the patient will receive.

Monaco helps indicate where clinicians can improve Elekta VMAT plans, according to Rob Cessac, Product Manager, Elekta Software. “By using biological optimization and Monte Carlo dose calculations, Monaco VMAT can help clinicians design timely and accurate treatment plans" he says. “The resulting plans are of similar quality to IMRT, but can be delivered in much less time, enabling a more efficient clinic and a better patient experience."

In advance of the full launch of Monaco 2.03, sites in Asia, Central America, Europe and the United States have clinically implemented the planning system for Elekta VMAT delivery.

For additional information, visit www.elekta.com/monacovmat.

 

###

For further information, please contact:
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email: stina.thorman@elekta.com
Time zone: CET: Central European Time
 
Michelle Lee Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time
 
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.